C12N 2770/38011
Tombusviridae
C12N2770/38011 (Tombusviridae) appears on 12 US grants and 21 published applications in this corpus.
Search patents in C12N- Granted patents
- 12
- Published applications
- 21
- Assignees
- 17
- Inventors
- 95
- Latest grant
- 21 Nov 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 2 |
| 2004 | 1 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 1 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 2 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 3 | 2 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 1 | 1 |
| 2021 | 0 | 3 |
| 2022 | 0 | 0 |
| 2023 | 4 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 2 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2770/38022New viral proteins or individual genes, new structural or functional aspects ofIndexing code7
- C12N 2770/38034Use of virus or viral component as vaccineIndexing code2
- C12N 2770/38061Methods of inactivation or attenuationIndexing code2
- C12N 2770/38023Virus like particles [vlp]Indexing code1
- C12N 2770/38041Use of virus, viral particle or viral elements as a vectorIndexing code1
- C12N 2770/38021Viruses as suchIndexing code0
- C12N 2770/38031Uses of virus other than therapeutic or vaccineIndexing code0
- C12N 2770/38032Use of virus as therapeutic agent, other than vaccineIndexing code0
All 12 subgroupsShow fewer
Recent patents
- Nanoparticles and biotemplates with tunable length and methods of manufacturing the same21 Nov 2023US 11,820,988 B2Purdue Research Foundation
- Vaccines formed by virus and antigen conjugation11 Jul 2023US 11,696,948 B2Kbio Holdings Limited
- Vaccines formed by virus and antigen conjugation4 Jul 2023US 11,690,907 B2Kbio Holdings Limited
- Simultaneous gene silencing and suppressing gene silencing in ihe same cell24 Jan 2023US 11,560,571 B2Commonwealth Scientific and Industrial Research Organisation
- Simultaneous gene silencing and suppressing gene silencing in the same cell3 Nov 2020US 10,822,615 B2Commonwealth Scientific and Industrial Research Organisation
- Artificial tombusviridae satellite rnas1 Oct 2026US 2026/0297598 A1Flagship Pioneering Innovations Vii, LLC
- Engineered Plant Virus-Based Nanoparticles and Intravenous Formulations Thereof for Autoimmune Therapy16 Jul 2026US 2026/0199518 A1
- Artificial viral capsid19 Feb 2026US 2026/0049107 A1AGC Inc.
- Mrna expression and delivery systems24 Jul 2025US 2025/0236645 A1Iowa State University Research Foundation, Inc.
- Use of interferon as an adjuvant in vaccines20 Feb 2025US 2025/0057946 A1Zoetis Services LLC
Most cited
By later US patents
- Genetics manipulations with recombinant DNA virus comprising sequences derived from RNA virus6US 6,093,554 AAveve N.V. · 2000
- Vaccines formed by virus and antigen conjugation5US 11,696,948 B2Kbio Holdings Limited · 2023
- Genetic manipulations with recombinant DNA comprising sequences derived from RNA virus4US 6,197,542 B1Aveve N.V. · 2001
- Vaccines formed by virus and antigen conjugation1US 11,690,907 B2Kbio Holdings Limited · 2023
- Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds1US 7,175,984 B22007